AI
CNMD icon

Atom Investors’s CONMED CNMD Stock Holding History

Atom Investors’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-9,939
Closed -$782K – 410
2020
Q3 		$782K Buy
9,939
+4,934
+99% +$402K 0.07% 219
2020
Q2 		$360K Buy
+5,005
New +$348K 0.02% 300
2019
Q1 		– Sell
-32,175
Closed -$2.07M – 543
2018
Q4 		$2.07M Buy
+32,175
New +$2.2M 0.2% 91

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Atom Investors's CNMD Position: Q4 2020 in Review

Atom Investors sold out of CONMED (CNMD) in Q4 2020, closing a stake of 9,939 shares — an estimated $782K sold.

Atom Investors first reported a position in CNMD in Q4 2018 and held it in 3 quarters. The position peaked at $2.07M in Q4 2018. 249 funds tracked by Wall St. Rank hold CNMD as of Q4 2020.

  • Atom Investors reported no remaining CONMED position as of Q4 2020 after selling out during the quarter.
  • Atom Investors sold 9,939 CONMED shares in Q4 2020, an estimated $782K.
  • Atom Investors first reported a position in CONMED in Q4 2018 and held it in 3 quarters.
  • Atom Investors's CONMED position peaked at $2.07M in Q4 2018.
  • 249 funds tracked by Wall St. Rank held CONMED as of Q4 2020.

Based on Atom Investors's 13F filing for Q4 2020, filed 16 Feb 2021.